Indefinite Delivery Contract HHSN271201700015I

The National Center for Advancing Translational Sciences (NCATS), a civilian agency, has awarded an indefinite delivery contract (IDC) worth up to $48,622,546 to Charles River Laboratories, Inc. to provide safety evaluation and toxicology studies and related services to support drug development. The contract has a period of performance from August 2024 to August 2030. Under this IDC, Charles River will perform in vitro and in vivo exploratory and Investigational New Drug (IND)-directed...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $48.6 million multiple-award indefinite delivery contract to conduct safety evaluation and toxicology studies in support of drug development. The contract has a 6-year ordering period and allows NCATS to issue task orders for in vitro and in vivo safety testing services, including genetic toxicology, general toxicology, and pharmacology...

This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) valued up to $17,887,012 to Organix Chemistry Solutions LLC for CRO Support for NCATS Medicinal Chemistry for Lead Optimization. Under this multiple-award IDC, Organix was issued two delivery orders to date. The first delivery order, valued at $3,677,412.09, provides synthetic chemistry support services to NCATS'...

The federal contract IDV award is for safety evaluation and toxicology studies and related services to support drug development efforts of the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The prime contractor, SRI International, a nonprofit research and development institute, will provide in vitro and in vivo exploratory and Investigational New Drug (IND)-directed toxicology studies for small molecule and biologic...

This indefinite delivery contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Lovelace Biomedical Research Institute, a not-for-profit contract research organization based in Albuquerque, New Mexico. The $17.89 million multiple-award contract, which runs through April 2025, is for contract research organization (CRO) support for NCATS' medicinal chemistry work focused on lead optimization. Under the...

This indefinite delivery contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The $17,891,012 multiple-award contract, which runs through April 2025, is for CRO support services related to NCATS' medicinal chemistry program for lead optimization. The initial $1,000...

This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $48.6 million multiple-award IDC has a 6-year ordering period from June 2024 to June 2030. The contract aims to procure safety evaluation and toxicology studies and related services to support drug development efforts at NCATS....

This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Alchem Laboratories Corporation. The contract, valued at up to $17,891,012, is to provide CRO (contract research organization) support services for NCATS's Medicinal Chemistry for Lead Optimization program. Under this multiple-award IDC, Alchem Laboratories will perform a variety of preclinical and...

This Indefinite Delivery Contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to the prime contractor Southern Research Institute, a non-profit research organization located in Birmingham, Alabama. The IDC, with a ceiling value of $17,891,012, is to provide CRO (Contract Research Organization) support for NCATS' Medicinal Chemistry for Lead Optimization program. This includes services...